INBS vs. MODD, NXL, BDMD, CLGN, MBOT, TMDIF, MDAI, NMTC, FEMY, and DXR
Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include Modular Medical (MODD), Nexalin Technology (NXL), Baird Medical Investment (BDMD), CollPlant Biotechnologies (CLGN), Microbot Medical (MBOT), Titan Medical (TMDIF), Spectral AI (MDAI), NeuroOne Medical Technologies (NMTC), Femasys (FEMY), and Daxor (DXR). These companies are all part of the "medical equipment" industry.
Intelligent Bio Solutions vs.
Intelligent Bio Solutions (NASDAQ:INBS) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.
Intelligent Bio Solutions has higher revenue and earnings than Modular Medical.
Modular Medical has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -323.79%. Intelligent Bio Solutions' return on equity of -146.03% beat Modular Medical's return on equity.
33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 0.3% of Intelligent Bio Solutions shares are owned by company insiders. Comparatively, 20.5% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Modular Medical has a consensus target price of $5.00, suggesting a potential upside of 358.72%. Given Modular Medical's stronger consensus rating and higher probable upside, analysts plainly believe Modular Medical is more favorable than Intelligent Bio Solutions.
Modular Medical received 2 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users.
In the previous week, Intelligent Bio Solutions had 5 more articles in the media than Modular Medical. MarketBeat recorded 5 mentions for Intelligent Bio Solutions and 0 mentions for Modular Medical. Intelligent Bio Solutions' average media sentiment score of 0.44 beat Modular Medical's score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.
Intelligent Bio Solutions has a beta of 4.72, suggesting that its share price is 372% more volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500.
Summary
Intelligent Bio Solutions beats Modular Medical on 8 of the 14 factors compared between the two stocks.
Get Intelligent Bio Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intelligent Bio Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:INBS) was last updated on 2/22/2025 by MarketBeat.com Staff
